Twist Bioscience completes acquisition of Abveris (AbX Biologics)

Twist Bioscience Corp

Acquisition closed December 1, 2021, under merger agreement dated November 19, 2021.
Twist issued stock consideration; entered Registration Rights Agreement to register resale of those shares.
No financial terms (deal value, premium, or expected impact) disclosed in the filing.

item 8.01 item 9.01

Twist Bioscience Corp filing history →

Source: SEC EDGAR

accession 0001193125-21-346678

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.